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Abstract. 
 
The overall DNA methylation level sharply 
decreases from the zygote to the blastocyst stage de-
spite the presence of high levels of DNA methyltrans-
ferase (Dnmt1). Surprisingly, the enzyme is localized in 
the cytoplasm of early embryos despite the presence of 
several functional nuclear localization signals. We 
 
mapped a region in the NH
 
2
 
-terminal, regulatory do-
main of Dnmt1 that is necessary and sufficient for cyto-
plasmic retention during early development. Alto-
gether, our results suggest that Dnmt1 is actively 
retained in the cytoplasm, which prevents binding to its 
DNA substrate in the nucleus and thereby contributes 
to the erasure of gamete-specific epigenetic informa-
tion during early mammalian development.
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NA methylation plays an important role in the reg-
ulation of gene expression and is essential for nor-
mal mammalian development. Until now very
little has been known about the regulation of DNA meth-
ylation in mammalian cells. The predominant DNA meth-
yltransferase, Dnmt1
 
1
 
, is also involved in genomic imprint-
ing and X-inactivation (Li et al., 1993; Panning and
Jaenisch, 1996), and Dnmt1-deficient mice die at mid-ges-
tation (Li et al., 1992). Dnmt1 is composed of a NH
 
2
 
-ter-
minal, regulatory domain and a COOH-terminal, catalytic
domain that is closely related to the bacterial C5-methyl-
transferases (Bestor et al., 1988; Leonhardt and Bestor,
1993). To date, two isoforms of Dnmt1 have been de-
 
scribed, a longer, somatic form of 
 
z
 
190 kD (Tucker et al.,
1996; Yoder et al., 1996) and a shorter, oocyte-specific
form of 
 
z
 
170 kD that is generated by an alternative pro-
moter and translation from a downstream start site (Gau-
det et al., 1998; Mertineit et al., 1998).
Recently, three additional DNA methyltransferases,
 
Dnmt2 (Okano et al., 1998b; Van den Wyngaert et al., 1998;
Yoder and Bestor, 1998) and Dnmt3 
 
a
 
 and 
 
b
 
 (Okano et
al., 1998a), have been identified but their role in vivo is
still unknown.
The most dramatic changes in the DNA methylation
pattern occur during gametogenesis and early develop-
ment (Monk et al., 1987; Sanford et al., 1987). During
oogenesis and spermatogenesis sex-specific methylation
patterns are established that are essentially retained
throughout development (Olek and Walter, 1997; Trem-
blay et al., 1997) and control the expression of imprinted
genes (reviewed in Constancia et al., 1998; Latham et al.,
1995).
During preimplantation development the overall meth-
ylation level sharply decreases and reaches a low point at
the blastocyst stage (Monk et al., 1987; Razin and Shemer,
1995). The mechanism responsible for this demethylation
is still unknown. DNA methylation activity (Howlett and
Reik, 1991; Monk et al., 1991) and Dnmt1 protein level are
very high in oocytes and preimplantation embryos but im-
munofluorescence studies have shown that Dnmt1 is local-
ized in the cytoplasm at these stages (Carlson et al., 1992;
Mertineit et al., 1998).
We report here the mapping of a region in the regula-
tory domain of Dnmt1 that is necessary and sufficient for
cytoplasmic localization during early development. Since
the same region is also present in the nuclear, somatic
form of Dnmt1, we postulate interacting factor(s) that are
expressed during early development and sequester Dnmt1
in the cytoplasm. This separation of Dnmt1 from its nu-
clear DNA substrates may contribute to the regulation of
DNA methylation during early development.
 
Materials and Methods
 
Translational Fusion Constructs
 
All translational fusions were generated by standard cloning protocols us-
ing the previously described plasmid pEMT that expresses the shorter, oo-
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Abbreviations used in this paper: 
 
DIC, differential interference contrast;
Dnmt, DNA methyltransferase; FHM, flushing-holding medium; HGG,
human chorionic gonadotropin; NLS, nuclear localization signal; p.c.,
post-coitum; PMS, pregnant mare’s serum.
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cyte-specific Dnmt1 isoform (Czank et al., 1991). Dnmt1 sequences
present in the fusions are indicated in the figures. In addition, amino acids
361–1061 of the 
 
Escherichia coli
 
 
 
b
 
-galactosidase were added in-frame at
the COOH terminus. In two cases, a short nuclear localization signal
(NLS) derived from SV-40 large T antigen (PKKKRKV) was added at the
NH
 
2
 
 terminus of some deletion constructs. Plasmid DNA was purified us-
ing Qiagen columns according to the manufacturer’s instructions.
 
Cell Culture and Transfection
 
Monkey COS1 cells and mouse fibroblast cells (C3H10T1/2 and NIH3T3)
were grown in a humidified incubator at 37
 
8
 
C and 5% CO
 
2
 
 in DME sup-
plemented with 10% fetal calf serum. Mouse C2C12 myoblast cells were
grown as above except that the media was supplemented with 20% fetal
calf serum.
COS1 cells were transfected with the DEAE-dextran pretreatment
method and 2 d later, cells were scraped, extracted, and the fusion pro-
teins analyzed by Western blotting as described in Leonhardt et al. (1992).
Mouse myoblast and fibroblast cells were transfected by the calcium
phosphate-DNA coprecipitation method followed by glycerol shock treat-
ment 
 
z
 
8–12 h later. 36–48 h after DNA addition, cells were fixed and
stained for the localization of the fusion protein.
 
Cultivation and Microinjection of Mouse Zygotes
 
Mouse embryos were obtained from FVB superovulated female mice
mated with C57BL/6 males. Female mice (
 
z
 
3–4 wk old) were injected in-
traperitoneally with 5 IU of pregnant mare’s serum (PMS) followed by an
intraperitoneal injection of 5 IU of human chorionic gonadotropin
(HGG) 46–48 h later to induce superovulation, which is necessary to ob-
tain an adequate amount of fertilized eggs upon mating. Matings were set
up with fertile stud males after the HGG injection.
Zygotes were collected from the oviduct of 0.5 d post-coitum (p.c.) do-
nors into flushing-holding medium (FHM) containing hyaluronidase (0.65
mg/ml), to remove the cumulus cells. After several washes in FHM, the
eggs were transferred to kSOM medium in microdrop cultures and incu-
bated in a humidified CO
 
2
 
 chamber at 37
 
8
 
C. Culture conditions and media
compositions have been described in detail (Lawitts and Biggers, 1993;
Hogan et al., 1994).
For injection, DNA fragments containing all the regulatory sequences
but lacking the prokaryotic vector part were used. DNA was purified with
standard glassmilk absorption techniques (Qiagen), resuspended in TE
buffer at a final concentration of 1–10 
 
m
 
g/ml. On average 1–2 pl were in-
jected into one of the pronuclei.
 
Immunofluorescence and Microscopy
 
Tissue culture fibroblast or myoblast cells were washed once with PBS,
fixed for 10 min in 3.7% formalin in PBS, and permeabilized with 0.25%
Triton X-100 in PBS for 10 min. After blocking 30 min in 3% BSA or
0.2% gelatin in PBS, cells were incubated for 60 min with mouse anti–
 
b
 
-galactosidase antibody (Promega) diluted 1:1,000. After extensive
washes with 0.1% NP-40 in PBS, cells were incubated for another 60 min
in FITC-conjugated goat anti–mouse (Boehringer Mannheim) or in bio-
tinylated goat anti–mouse IgG antibodies (Amersham), the latter followed
by washing and 30 min incubation in streptavidin–Texas red (Amersham)
as described before (Cardoso et al., 1993). DNA was counterstained with
Hoechst 33258 and cells were mounted in mowiol with 2.5% DABCO
(Cardoso and Leonhardt, 1995). All dilutions were made in 3% BSA or
0.2% gelatin in PBS, and all incubations were carried out at room temper-
ature.
Specimens were examined and photographed on Zeiss Axiophot and
Axiovert microscopes equipped with phase-contrast and epifluorescence
optics, using 63
 
3
 
 and 100
 
3
 
 plan-apochromat and plan-neofluor lenses.
Pictures were taken with Kodak Ektar 100 film.
Mouse embryos were fixed and stained in microtiter plate wells and
moved from one solution to the other with handmade capillaries under a
stereo microscope. The staining procedure was as above using mouse anti–
 
b
 
-galactosidase antibody or rabbit antisera to Dnmt1 (Leonhardt et al.,
1992), the latter followed by FITC-conjugated goat anti–rabbit IgG anti-
body (Boehringer Mannheim). Embryos were mounted in mowiol with
2.5% DABCO on 8-well multitest slides.
Stained embryos were analyzed on a Zeiss Axiophot microscope
equipped with differential interference contrast (DIC), epifluorescence,
and confocal laser scanning system using 40
 
3
 
 and 63
 
3
 
 plan-neofluor
lenses. Epifluorescence and DIC images were recorded on film as de-
 
scribed above. Optical sections were obtained using the Bio-Rad MRC-
600 confocal imaging system and micrographs were taken on Kodak Tmax
400 film. Images were scanned, assembled, and annotated with Adobe
Photoshop on a Power Macintosh computer and printed on a Phaser 440
dye sublimation printer (Tektronix).
 
Results and Discussion
 
Cytoplasmic Localization of Dnmt1 during 
Preimplantation Development
 
To study the mechanism responsible for the cytoplasmic
localization of Dnmt1 during preimplantation develop-
ment, we first tested whether this phenomenon can be re-
produced in embryos that are cultured in vitro. Fertilized
mouse eggs were collected at the one-cell stage and were
cultured in vitro for up to 4 d. Under optimal conditions
embryos develop until the blastocyst stage. Embryos were
collected and fixed at different stages of preimplantation
development and then stained for Dnmt1 with a specific
polyclonal antiserum raised against the NH
 
2
 
-terminal do-
main of Dnmt1. The localization of Dnmt1 was then deter-
mined by confocal analyses (Fig. 1). Dnmt1 was localized
in the cytoplasm of one-, two-, and four-cell embryos as
well as in blastocysts. Only at the eight-cell stage was the
enzyme found in the nucleus. These results are in good
agreement with previous studies on naturally developed
embryos (Carlson et al., 1992), and show that the develop-
mentally controlled subcellular localization of Dnmt1 can
be reproduced with in vitro cultured embryos.
 
Dnmt1 Contains Several Functional NLS
 
In somatic cells, Dnmt1 is strictly localized in the nucleus
and is targeted to replication foci during S-phase (Leon-
hardt et al., 1992). This raises the question how Dnmt1 en-
ters the nucleus of somatic cells but remains in the cyto-
plasm during most of preimplantation development.
One possible explanation for this different localization
could be the fact that different isoforms are expressed in
these cells. Indeed, the Dnmt1 gene is transcribed from
different promoters and a 118–amino acid shorter isoform
of Dnmt1 was identified in oocytes and preimplantation
embryos (Gaudet et al., 1998; Mertineit et al., 1998).
Therefore, we expressed this shorter isoform in different
somatic cell lines including COS1, mouse fibroblasts, and
myoblast cells. For visualization by immunofluorescence,
the oocyte-specific isoform was fused with an unrelated
 
b
 
-galactosidase epitope. In all tested somatic cell lines the
fusion protein showed a clear nuclear localization like the
longer somatic isoform (data not shown). To further study
the regulation of the nuclear uptake of Dnmt1, we gener-
ated a set of deletion mutants and determined their sub-
cellular localization (Fig. 2). A series of deletions showed
that the first 139 amino acids of the oocyte-specific form
are sufficient for nuclear uptake of the 
 
b
 
-galactosidase fu-
sion in somatic cells. Deletion of one candidate NLS
(KKRR from position 72–92) prevented nuclear uptake.
This region clearly contains a functional NLS since this se-
quence alone allows nuclear uptake of the fusion protein
(Fig. 2). The regulatory domain of Dnmt1, however, con-
tains further stretches of basic amino acids that could
serve as NLS. Further deletion constructs identified at
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least two independent additional NLS (positions 140–259
and 511–638). These results clearly show that the oocyte-
specific Dnmt1 form enters the nucleus of somatic cells
and contains at least three independent NLS. Though
these three regions function as NLS, a set of internal dele-
tions (from positions 310–637, 310–511, 511–637, and 636–
972) that retain all three NLS or at least the two first NLS
show cytoplasmic localization of the fusion protein in so-
matic cells (Fig. 2). Similar deletions constructs (not fused
to 
 
b
 
-galactosidase) expressed in mammalian cells are en-
zymatically inactive (Margot, J.B., A.M. Aguirre-Arteta,
V. Di Giacco, S. Pradhan, R. Roberts, M.C. Cardoso, and
H. Leonhardt, manuscript submitted for publication) sug-
gesting an important role of this region in the proper fold-
ing of Dnmt1, rather than a specific effect on nuclear local-
ization.
 
Mapping of a Cytoplasmic Retention Sequence
in Dnmt1
 
The fact that Dnmt1 contains at least three independently
functional NLS raises the question of how the oocyte-spe-
cific form is maintained in the cytoplasm during early de-
velopment. This cytoplasmic localization of Dnmt1 could
Figure 1. Localization of Dnmt1 in early mouse embryos. During preimplantation development, Dnmt1 localizes to the cytoplasm of
one- (A), two- (B), and four- (C) cell embryos, it is partly imported into the nuclei with the remaining protein staying in the cytoplasm
at the eight-cell stage (D), and it is again out of the nucleus at the blastocyst stage (E). Fertilized mouse embryos were collected and in-
cubated in vitro. At different times, the embryos were fixed and stained with an anti-Dnmt1 polyclonal antibody and analyzed by confo-
cal microscopy. The images show single confocal sections through embryos at different stages of development. Bar, 10 mm.
Figure 2. Dnmt1 has at least three independent nuclear localization signals. (A) Diagram outlining the structure of the oocyte-specific
murine Dnmt1 protein and indicating the different parts of the Dnmt1 present in fusions with the b-galactosidase epitope (for simplic-
ity, the latter is not depicted). The different fusion constructs were expressed in murine myoblast or fibroblast cells, formalin fixed,
stained with anti–b-galactosidase monoclonal antibody, and screened for their nuclear or cytoplasmic localization. B shows a represen-
tative example of a cytoplasmic fusion protein containing amino acids 1-72; 92-139 of Dnmt1 and C shows a nuclear fusion protein con-
taining amino acids 1-72; 92-259 of Dnmt1, including only the second NLS. The analysis of all listed constructs lead to the identification
of three regions (highlighted by grey shading) that contain independently functional NLS. Sequences representing possible NLS within
each shaded area are specified below. The black box indicates the location of the cysteine-rich region that had been shown to bind zinc
ions (Bestor, 1992). Bar, 10 mm.
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be caused by alternative splicing leading to the expression
of an isoform without functional NLS. Alternatively,
trans-acting factors could be present in the oocyte and
early embryo that prevent nuclear localization of Dnmt1.
To test these hypotheses, we established an experimental
approach to analyze deletion constructs of Dnmt1 in early
embryos (Fig. 3).
To identify sequences controlling subcellular localiza-
tion in early embryos and to visualize truncated proteins
by immunofluorescence, we fused the shorter, oocyte-spe-
cific open reading frame of Dnmt1 with the unrelated
 
b
 
-galactosidase gene. These fusion constructs were cloned
into a mammalian expression vector and injected into fer-
tilized mouse eggs. These injected eggs were cultured in
microdrops and fixed and stained at different time points.
Fusion proteins were detected with 
 
b
 
-galactosidase-spe-
cific antibodies and their localization analyzed by confocal
microscopy. Fig. 3 b shows a two-cell embryo expressing
an almost full-length Dnmt1 (amino acids 1–1,490) fused
to 
 
b
 
-galactosidase. This fusion protein is clearly localized
in the cytoplasm just like the endogenous Dnmt1 protein
at this stage. The same fusion protein has also been tested
in somatic cells and was found in the nucleus ruling out
possible artifacts caused by the fusion (data not shown). In
other words, this experimental system reproduces the sub-
cellular localization of Dnmt1: the fusion protein is local-
ized in the nucleus of somatic cells and in the cytoplasm of
early embryos. Since embryos are known to have a high
level of autofluorescence control embryos were injected
with TE buffer alone and analyzed in parallel (Fig. 3 a).
The comparison with expressing embryos shows that the
obtained signals are clearly distinguishable from the auto-
fluorescence. Moreover, a truncated fusion protein com-
prising amino acids 1–259 including the first two NLS of
Dnmt1 was clearly localized in the nucleus of two-cell em-
bryos (Fig. 3 c) ruling out unspecific retention of the fusion
protein caused by the 
 
b
 
-galactosidase part. Finally, a fu-
sion protein containing amino acids 1–638 exhibited an in-
termediate phenotype with less efficient cytoplasmic re-
tention (Fig. 3 d). These results clearly show that this
experimental system is suitable for the identification of se-
quences that control subcellular localization during early
development.
The comparison of the full-length and the truncated fu-
sion protein in Fig. 3 suggests that Dnmt1 contains oocyte-
specific retention sequences, since both fusions contain
functional NLS. Therefore, we generated a set of deletions
to map that putative retention sequence (Fig. 4). All con-
structs shown in this figure were first tested in somatic
cells and showed a clear nuclear localization (data not
shown). A deletion series coming from the COOH-termi-
 
Figure 3.
 
Experimental strategy to map domains of Dnmt1 re-
sponsible for cytoplasmic localization in preimplantation mouse
embryos. A series of translational fusions containing different
parts of Dnmt1 in frame with 
 
b
 
-galactosidase was constructed in
mammalian expression vectors. The corresponding plasmid
DNA was then microinjected into one of the pronuclei of fertil-
ized mouse eggs. The injected eggs were incubated for 1 or 2 d in
vitro, after which they were formalin fixed and stained with anti–
 
b
 
-galactosidase mAb followed by FITC or rhodamine-conju-
gated secondary Ab. After mounting, the localization of the fu-
sion protein was analyzed by confocal laser scanning microscopy.
The background level was evaluated in each injection series by
staining and analyzing TE buffer injected embryos in parallel
with plasmid DNA (diluted in TE) injected ones. An optical sec-
tion of one such TE negative control embryos is shown in a. In
order for this assay to work, the oocyte-specific Dnmt1 fused to
 
b
 
-galactosidase should mimic the endogenous Dnmt1 protein lo-
calization. One representative confocal section through an em-
bryo injected with a construct containing amino acids 1–1,490 is
shown in b and exhibits the same cytoplasmic localization as the
endogenous protein (Fig. 1 and Carlson et al., 1992). As a further
step in testing this experimental strategy, some deletion mutants
of Dnmt1 should localize in the nucleus and therefore be scored
as negative for cytoplasmic retention. In c is depicted one confo-
cal section through an embryo injected with an expression plas-
mid containing only the first 259 amino acids of the oocyte-spe-
cific Dnmt1 isoform fused to 
 
b
 
-galactosidase. This fusion protein
 
is clearly not retained in the cytoplasm as the endogenous Dnmt1
at this stage of the preimplantation development. Instead, it
shows exclusive nuclear localization with the exception of the nu-
cleolar compartment as does the Dnmt1 present in somatic cells
(Leonhardt et al., 1992). Finally, an intermediate phenotype with
less efficient cytoplasmic retention is observed. In d is shown a
confocal section through an embryo injected with an expression
construct containing amino acids 1–638 of the oocyte-specific
Dnmt1 isoform illustrating this latter phenotype. Bar, 10 
 
m
 
m.
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nal end indicated that the first 638 amino acids of the regu-
latory domain of Dnmt1 are sufficient for retention in the
cytoplasm and that the catalytic domain is not required
(Fig. 4 D, I). A similar deletion series starting from the
NH
 
2
 
 terminus is not possible since the major NLS is lo-
cated between amino acids 72 and 92. Therefore, internal
deletions were done to further narrow down the region in-
volved in cytoplasmic retention. These deletions showed
that fusions containing the region from amino acid 308–
854 are efficiently retained in the cytoplasm and constructs
containing the region from amino acid 427–638 were still
retained but less efficiently so that some signal could also
be detected in the nucleus (see also Fig. 3 d). We propose
that the binding interface mediating the cytoplasmic reten-
tion is complex and may involve several stretches of amino
acids from different parts of the primary sequence. Dele-
tion of some of these interacting parts may reduce but not
totally abolish the affinity for the target(s). Similarly, dele-
tions may affect the three-dimensional structure of the in-
terface and thereby reduce the binding affinity and thus
cause some leakage into the nucleus.
In the center of this retention sequence lies the cysteine-
rich region that had been shown to bind zinc ions (Bestor,
1992). To test whether this region is involved in the cyto-
plasmic retention we deleted this region in the full-length
fusion construct. However, all deletions in this region as
well as in neighboring regions caused an aberrant cyto-
plasmic localization even in somatic cells despite the fact
that they all contained several functional NLS (Fig. 2 and
data not shown).
One possible explanation could be that the remaining
functional NLS were sequestered by an aberrant globular
folding of the deletion construct. In fact, similar results
were obtained in deletion studies to map the catalytic cen-
ter of Dnmt1 (Margot, J.B., A.M. Aguirre-Arteta, V. Di
Giacco, S. Pradhan, R. Roberts, M.C. Cardoso, and H. Le-
onhardt, manuscript submitted for publication; Zimmer-
mann et al., 1997). Several deletions in the NH
 
2
 
-terminal
domain affected the activity of the COOH-terminal, cata-
lytic domain. These results suggest that the NH
 
2
 
-terminal
domain has a complex folding that is required for efficient
cytoplasmic retention as well as for protein functions lo-
cated in other parts of the protein.
To test whether the retention sequence is dominant over
Figure 4. Dnmt1 is actively
retained in the cytoplasm of
early mouse embryos via a
sequence in the NH2-termi-
nal, regulatory domain of the
enzyme. A–D show the local-
ization of a b-galactosidase
fusion protein containing
amino acids 1–638 of the oo-
cyte-specific Dnmt1 isoform
which is retained in the cyto-
plasm of two-cell mouse em-
bryos. A shows the DIC im-
age; B shows the DNA
stained with Hoechst 33258;
C shows the rhodamine de-
tection of the b-galactosidase
fusion protein; and D shows
the corresponding confocal
section clearly showing its cy-
toplasmic localization. E–H
illustrate a cytoplasmic re-
tention deficient b-galactosi-
dase fusion protein contain-
ing amino acids 1–259 of the
oocyte-specific Dnmt1 iso-
form, as DIC image (E),
DNA staining (F), epifluo-
rescence image of the fusion
protein (G), and respective
confocal section (H). The dotty cytoplasmic signal visible in the confocal section in H was not reproducible. Fertilized eggs were micro-
injected with the different fusion constructs schematically shown in I (b-galactosidase was fused at the COOH terminus and it is not
shown), processed as described in Fig. 3, and assayed for their ability to be retained in the cytoplasm of two-cell mouse embryos. The
previously identified targeting sequence that directs the protein to subnuclear sites of DNA replication (Leonhardt et al., 1992) is indi-
cated in green. The diamond at the NH2 terminus of two fusions signifies the addition of an SV-40 large T antigen NLS. All the con-
structs listed show a clear nuclear localization in somatic cells (data not shown). The deletion endpoints of the different fusion proteins
shown in I define a broad region between amino acids 308 and 854 of the oocyte-specific Dnmt1 isoform (light grey shading) which is
necessary and sufficient for cytoplasmic retention (scored as 11) in preimplantation mouse embryos. Within this larger region the most
crucial sequence (dark grey shading) lies between amino acids 427 and 638, since deletions in this region are clearly not retained in the
cytoplasm (scored as 2). Absence of amino acids 308–427 or 638–854 flanking this sequence caused a less efficient cytoplasmic reten-
tion (scored as 1). Bars, 10 mm.
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heterologous NLS that are derived from an unrelated pro-
tein we added the SV-40 NLS at the NH
 
2
 
 terminus of the
full-length fusion construct. As summarized in Fig. 4, the
addition of the SV-40 NLS could not affect nuclear uptake
suggesting that the regulatory domain of Dnmt1 in fact
contains a dominant cytoplasmic retention sequence.
 
Dnmt1 Is Actively Sequestered in the Cytoplasm of 
Early Embryos
 
The fact that this retention sequence is dominant over a
heterologous NLS suggests that it does not act through
a specific modification or masking of the endogenous
Dnmt1 NLS but through active retention by a retention
factor and binding to some immobile cytoplasmic struc-
tures. Confocal images of endogenous Dnmt1 staining had
shown stronger signal in the peripheral cytoplasm and
were taken as indication that Dnmt1 binds to some struc-
tures at the cell membrane (Carlson et al., 1992). Similar
results were also obtained in this study (Fig. 1) and were
also reproduced with the fusion proteins (Figs. 3 and 4).
However, very different results were obtained using regu-
lar fluorescence microscopy showing an uniform distribu-
tion throughout the cytoplasm (Fig. 4 C, G). Interestingly,
the same embryos viewed by confocal microscopy showed
again the peripheral signals (Fig. 4 D, H). These results
suggest that the extreme peripheral staining signals seen in
the confocal are most likely an optical artifact. Due to light
absorption by the sample, the intensity of the excitation
light decreases as it penetrates the specimen and the inner
fluorophores are not excited to the same extent as the
outer ones (Taylor and Salmon, 1989). This inner filter ef-
fect is particularly evident in thick specimens like mouse
embryos and results in stronger peripheral signal. How-
ever, in fluorescence microscopy, out of focus light from
layers above and below is also detected compensating this
absorption effect. In other words, a detailed localization of
Dnmt1 is not possible with either method and further ul-
trastructural analyses by, e.g., electron microscopy, are
needed to clarify this issue and to provide clues as to what
structures Dnmt1 binds to in the cytoplasm of oocytes and
early embryos.
An interesting possible mechanism could involve an al-
losteric control through interacting factors. Since the fold-
ing of the NH
 
2
 
-terminal domain (in particular amino acids
300–1,000) seems to be complex and required for functions
residing in other part of the protein, it seems possible that
interacting proteins might affect the globular folding of
Dnmt1 and thereby inactivate the NLS similar to the inter-
nal deletions in somatic cells (see Fig. 2).
One further prediction from these experiments is that if
Dnmt1 is actively retained rather than modified in an en-
zymatic process, then retention should be saturable. In
fact, injection of a four times higher amount of plasmid
DNA resulted in cytoplasmic and nuclear localization of
the fusion protein (data not shown). Also longer incuba-
tion of injected embryos lead to an accumulation of the fu-
sion protein and gradual uptake into the nucleus (data not
shown). Although these results were clear, one has to keep
in mind that injecting these high amounts of plasmid DNA
disturbs normal development of mouse embryos. With this
cautionary note, these results suggest that the retention of
Dnmt1 is indeed saturable.
All tested Dnmt1 fusion constructs are relatively large,
ranging in size from 100 kD to 
 
z
 
250 kD. Although this
size range does not make any difference for nuclear up-
take in somatic cells, we generated a similar fusion con-
struct of equal size using the DNA ligase I, which is in-
volved in DNA replication and is like Dnmt1 targeted to
nuclear replication foci (Cardoso et al., 1997). Fig. 5 shows
the side-by-side comparison of both the Dnmt1 and the
DNA ligase I construct. In somatic cells, both fusion con-
structs are targeted to nuclear replication foci, but only the
DNA ligase fusion protein enters the nucleus of early
mouse embryos. These results clearly show that the ob-
served cytoplasmic retention of fusion proteins is specific
for the Dnmt1 protein and is developmentally controlled.
Moreover, the retention mechanism is active also in early
preimplantation embryos and not only in oocytes, where
the maternal stock of Dnmt1 is accumulated.
Figure 5. Cytoplasmic retention of Dnmt1 is independent of pro-
tein size. Two b-galactosidase fusion constructs were generated,
one containing amino acids 1–854 of Dnmt1 (depicted in the dia-
gram, Fig. 4 I) and the other containing amino acids 1–796 of hu-
man DNA ligase I (Cardoso et al., 1997). The size of both fusion
proteins is between 160–170 kD. Both plasmids were transfected
into mouse fibroblasts and microinjected into fertilized mouse
eggs. After a 1-d incubation, localization of the fusion proteins
was assayed by immunofluorescence staining with anti–b-galac-
tosidase monoclonal antibody. A shows a confocal section
through the middle of a mouse embryo expressing the Dnmt1 fu-
sion which is mostly cytoplasmic. B shows the DNA ligase I fu-
sion expressed in mouse embryos, which clearly has an exclusive
nuclear localization. C and D illustrate the localization of the
same proteins as in A and B, respectively, in the nuclei of tissue
culture cells, in these images undergoing S-phase as seen by the
ring and dot-shaped pattern of subnuclear foci (Leonhardt et al.,
1992; Cardoso et al., 1997). Bar 10 mm.
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The data presented in this work suggest that Dnmt1 is
actively retained in the cytoplasm, but cannot rule out the
formal possibility that Dnmt1 is enriched in the cytoplasm
by a nuclear export mechanism. However, the mapping of
a cis-acting sequence allows now a specific search for in-
teracting factors and the generation of dominant-negative
mutants to further study the regulation and role of the cy-
toplasmic localization of Dnmt1 during early develop-
ment.
The active retention of Dnmt1 in the cytoplasm from
the oocyte to the blastocyst stage correlates well with the
overall decrease in the genomic methylation level and thus
is a likely mechanism to regulate DNA methylation by
separating Dnmt1 from chromosomal DNA in the nu-
cleus. Demethylation could occur by preventing mainte-
nance methylation of newly synthesized DNA strands and/
or by preventing remethylation of actively demethylated
sites.
Recently, a cDNA coding for a protein with demeth-
ylase activity was isolated from HeLa cells and shown to be
ubiquitously expressed at the mRNA level in somatic cells
(Bhattacharya et al., 1999). It is still unknown whether it is
active during early development and the fact that this
demethylase is ubiquitous means that it cannot by itself
cause the specific demethylation during preimplantation
development.
Cytoplasmic accumulation of maternal nuclear gene
products has been extensively observed during oocyte
maturation and early development in 
 
Xenopus
 
 (Dabau-
valle and Franke, 1984; Paine, 1984; Dreyer, 1987). Some
transcription factors (e.g., Oct-1 and Xnf7; Li et al., 1994;
Veenstra et al., 1999) are retained in the cytoplasm until
the mid-blastula stage when transcriptional activity is re-
started. Nuclear exclusion in this developmental system
has been proposed as a mechanism to control the function
of maternal proteins until the time during development
when they are required. These results parallel the regula-
tion of Dnmt1 nuclear uptake during mammalian preim-
plantation development. Until the blastocyst stage, Dnmt1
is retained in the cytoplasm with the exception of the
eight-cell stage when it briefly enters the nucleus (Fig. 1 D;
Carlson et al., 1992). Also, in growing oocytes, Dnmt1 en-
ters the nucleus at a time when parasitic sequences are
heavily methylated (Walsh et al., 1998). Analogously, it is
conceivable that specific sequences are methylated at the
eight-cell stage. In that regard, it is interesting to note
that modifications occur in eight-cell stage embryos that
make them unable to recapitulate the normal program of
gene expression when transplanted into one-cell embryos
(Latham et al., 1994). This different behavior of trans-
planted nuclei from two- and eight-cell embryos might in
part be caused by methylation of specific genomic DNA
sequences around the eight-cell stage. In fact, the 
 
Igf2r
 
gene locus is methylated exactly at the eight-cell stage and
could thus be one such candidate genes (Birger et al.,
1999).
The high level of the enzyme in oocytes possibly repre-
sents a maternal stock to be used for maintenance and/or
de novo methylation in later cell cycles. This large amount
would last through subsequent cell divisions and might
thus also allow development of Dnmt1-deficient mice till
mid-gestation. In this context, it is noteworthy that the oo-
 
cyte-specific Dnmt1 isoform is fully active, can restore
DNA methylation in 
 
Dnmt1
 
-null embryonic stem cells,
and can thus rescue their capacity to differentiate in vivo
(Gaudet et al., 1998).
In addition, one cannot exclude that Dnmt1 might also
have a function in the cytoplasm during early develop-
ment, in particular since this cytoplasmic store is enzymat-
ically active. Interestingly, the bacterial restriction-modifi-
cation system is also localized in the periplasmic space and
serves as a first line of defense against foreign DNA. One
possible function of the high concentration of Dnmt1 in
the cytoplasm could be to protect the developing embryo
and the future germ line by methylating intruding DNA
and thus rendering it transcriptionally inactive. The identi-
fication and characterization of a cytoplasmic retention se-
quence makes it now possible to directly investigate func-
tions of Dnmt1 during early development and to screen
for interacting factors.
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